Telmisartan
Showing 1 - 25 of 347
Essential Hypertension, Metabolic Syndrome Trial (Telmisartan, Losartan)
Not yet recruiting
- Essential Hypertension
- Metabolic Syndrome
- Telmisartan
- Losartan
- (no location specified)
May 3, 2023
Essential Hypertension Trial in Korea, Republic of (Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg,
Not yet recruiting
- Essential Hypertension
- Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
- Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
-
Seoul, Gyeonggi-do, Korea, Republic of
- +11 more
Sep 11, 2023
Patients Treated With Telmisartan/Hydrochlorothiazide or
Withdrawn
- Hypertension
- subjects treated with telmisartan/hydrochlorothiazide
- +3 more
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Jun 23, 2022
Hypertension, Diabetes, Type 2 Trial in Seoul (THP-00101 (Dapagliflozin) 10mg, THP-00102 (Telmisartan) 80mg)
Recruiting
- Hypertension
- Diabetes Mellitus, Type 2
- THP-00101 (Dapagliflozin) 10mg
- THP-00102 (Telmisartan) 80mg
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Sep 25, 2023
Diabetic Nephropathy Trial in Nice (telmisartan during 6 months, Losartan during 6 months, blood sample)
Completed
- Diabetic Nephropathy
- telmisartan during 6 months
- +2 more
-
Nice, FranceCHU de Nice
May 13, 2022
COVID-19 Infection Trial in Strasbourg (Hydroxychloroquine, Azithromycin, Telmisartan)
Terminated
- COVID-19 Infection
- Hydroxychloroquine
- +2 more
-
Strasbourg, FranceCHU de Strasbourg
Jul 7, 2022
Covid19 Trial in Honolulu (Telmisartan Oral Product, Placebo)
Terminated
- Covid19
- Telmisartan Oral Product
- Placebo
-
Honolulu, HawaiiQueen's Medical Center
Jun 27, 2022
COVID-19 Trial in Honolulu (Telmisartan 40mg, Placebo)
Terminated
- COVID-19
- Telmisartan 40mg
- Placebo
-
Honolulu, HawaiiUniversity of Hawaii - Manoa, John A Burns School of Medicine UH
Jun 27, 2022
Schizophrenia, Schizo Affective Disorder, Treatment-resistant Schizophrenia Trial in Worcester (Telmisartan Pill)
Terminated
- Schizophrenia
- +2 more
- Telmisartan Pill
-
Worcester, MassachusettsUMass Psychotic Disorders Research Program
Feb 7, 2022
Neuropathic Pain, Chemo Effect Trial in Frankfurt (Telmisartan tablets)
Recruiting
- Neuropathic Pain
- Chemotherapy Effect
- Telmisartan tablets
-
Frankfurt, GermanyDepartment of Haematology/Medical Onkology, University Hospital,
Apr 4, 2022
GVHD Trial in Hackensack (Telmisartan)
Active, not recruiting
- GVHD
- Telmisartan
-
Hackensack, New JerseyHackensack University Medical Center
Sep 2, 2022
Hypertension, Potassium Imbalance Trial in Dhaka (Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg)
Recruiting
- Hypertension
- Potassium Imbalance
- Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg
-
Dhaka, BangladeshNational Heart Foundation of Bangladesh
Jan 21, 2022
Hypertension Trial in Australia, United States (Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg, Telmisartan 20
Recruiting
- Hypertension
- Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg
- +2 more
-
Tampa, FloridaPrecision Research Center
Dec 13, 2021
Peripheral Artery Disease Trial in Chicago, New Orleans (behavioral, drug, other)
Recruiting
- Peripheral Artery Disease
- Supervised Treadmill Exercise Therapy
- +3 more
-
Chicago, Illinois
- +2 more
Aug 10, 2021
Heart Failure With Reduced Ejection Fraction, Renal Insufficiency Trial in Cairo (Telmisartan)
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Renal Insufficiency
- Telmisartan
-
Cairo, EgyptKasralainy hospital, faculty of medicine, Cairo university
Jul 27, 2021
Hypercholesterolemia, Hypertension Trial in Seoul (Ezetimibe/Rosuvastatin, Telmisartan, Telmisartan/Amlodipine 80 Mg-5 Mg ORAL
Completed
- Hypercholesterolemia
- Hypertension
- Ezetimibe/Rosuvastatin
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 10, 2021
Hypertension Associated, Type II Diabetes Trial (Egito, Empagliflozin + telmisartan)
Not yet recruiting
- Hypertension Associated
- Type II Diabetes Mellitus
- Egito
- Empagliflozin + telmisartan
- (no location specified)
Aug 3, 2022
Hypertension, Dyslipidemia Trial in Seoul (Duowell®, Telmisartan)
Completed
- Hypertension
- Dyslipidemia
- Duowell®
- Telmisartan
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 4, 2021
ASCVD, Impaired Fasting Glucose, Hypertension Trial in Seongnam-si, Cheonan, Seoul (Duowell®, Monorova® + Amlopin®)
Completed
- ASCVD
- +2 more
- Duowell®
- Monorova® + Amlopin®
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +3 more
May 31, 2021
Hypertension,Essential Trial in Seoul (AD209, Amlodipine low, Amlodipine high)
Completed
- Hypertension,Essential
- AD209
- +3 more
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Jul 20, 2021
Hypercholesterolemia, Hypertension Trial in Seoul (Ezetimibe/Rosuvastatin, Telmisartan)
Completed
- Hypercholesterolemia
- Hypertension
- Ezetimibe/Rosuvastatin
- Telmisartan
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 13, 2021
COVID-19 Drug Treatment Trial in Buenos Aires, Ciudad Autonoma de Buenos Aires (Telmisartan arm will receive 80 mg Telmisartan
Completed
- COVID-19 Drug Treatment
- Telmisartan arm will receive 80 mg Telmisartan twice daily plus standard care.
-
Buenos Aires, Ciudad De Buenos Aires, Argentina
- +1 more
Dec 23, 2020
Hypertension Trial in Cheongju-si (Telminone 80 mg, Drug: Micardis 80 mg)
Recruiting
- Hypertension
- Telminone 80 mg
- Drug: Micardis 80 mg
-
Cheongju-si, Chungcheongbuk-do, Korea, Republic ofChungbuk National University Hospital
Feb 14, 2022